RxDoctor Payments Data

Arun Paul, MD

Radiation Oncology · Seattle, WANPI 1376898411

Payments from drug & device makers

$285in general payments, 2019–2025

Across 14 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$92
  • Bayer$41
  • Boston Scientific$37
  • Novartis$32
  • Brainlab, Inc.$23
  • Tactile Systems Technology Inc$22
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$285 in reported general payments places this provider in the 45th percentile of 168 radiation oncology providers in Washington.

See all radiation oncology providers in Washington

Medicare billing

Part B allowed, 2024
$31,010
Medicare patients
79
Services billed
428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl14$32

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →